Skip to main content

Point72 Asset Management, L.P.

Position in NKTR — Nektar Therapeutics

CIK 1603466 STAMFORD, CT

Position in NKTR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$961,539
-$17,363,416 QoQ
Shares Held
13,364
-96.9% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Derivatives in NKTR

reported options exposure · as of Dec 31, 2025
CallValue
$380,520
CallShares
9,000
PutValue
$380,520
PutShares
9,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in NKTR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $961,539 13,364
2025-12-31 $380,520 9,000
2025-12-31 $380,520 9,000
2025-12-31 $18,324,955 433,419
2025-09-30 $1,849,250 32,500
2025-09-30 $1,849,250 32,500
2025-09-30 $7,036,140 123,658
2023-09-30 $912,346 1,520,578
2023-06-30 $13,258 22,859
2022-03-31 $2,392,082 443,800
2021-12-31 $6,245,673 462,300
2021-09-30 $9,466,716 527,100
2020-03-31 $279,852 15,678